# CatalYm GmbH: Research, Planegg, Germany

> CatalYm GmbH: CatalYm GmbH is a clinical-stage biopharmaceutical company based in Martinsried, Germany. Based in Planegg, Germany. Founded 2016.

Source: https://millionrounds.com/startup/catalym-gmbh (Millionrounds; every figure on the page links to its filing or article)

Germany · [Research startup](https://millionrounds.com/companies)

# CatalYm GmbH

CatalYm GmbH is a clinical-stage biopharmaceutical company based in Martinsried, Germany.

Funding reported Last round: Series D

Research Planegg, Germany

Company summary

- **Founded:** 2016 10 years old
- **Team:** 56 51 to 200 people
- **Funding reported:** 260.9M as listed, currency not stated
- **Last round:** Series D Jul 2024

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for CatalYm GmbH has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## About CatalYm GmbH

CatalYm GmbH is a clinical-stage biopharmaceutical company based in Martinsried, Germany.

Founded in 2016 as a spin-out from the Julius-Maximilians-University of Würzburg, the company focuses on developing innovative cancer immunotherapies that target the protein GDF-15. Their mission is to enhance the immune system's ability to treat solid tumors, particularly by converting "cold" tumors into "hot" ones that respond to treatment. The company's lead product candidate, Visugromab (CTL-002), is a first-in-class antibody designed to neutralize GDF-15, a protein that suppresses immune responses. By blocking GDF-15, Visugromab aims to improve the effectiveness of existing immunotherapies. CatalYm has raised significant funding, including a $150 million financing round, to support the development of Visugromab, which has shown promising results in early clinical trials for patients with relapsed and refractory metastatic solid tumors. The company collaborates with pharmaceutical firms and academic institutions to advance its research and drug development efforts.

## What company datasets say CatalYm GmbH raised

Funding, as reported

Reported in all **260.9M** in the source's currency

Rounds **4**

Last round **Series D**

Last round size **150M**

Last round date **Jul 2024**

Investors listed **14**

## On a portfolio page

Investors who name them

- [Jeito Capital](https://millionrounds.com/fund/jeito-capital)

Each firm lists CatalYm GmbH on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

## The company, in detail

What they build

Known for

health care tumor microenvironment biotechnology research resistance reversal tumor infiltration cancer therapy visugromab immunology gdf-15 mechanistic research medical research combination therapy gdf-15 pathway monoclonal antibody pharmaceutical hospital & health care cytokine

Built with from their website

Google Maps Contact Form 7 ServiceNow Virtual Agent WordPress.org Ionicons Font Awesome Olo Max Mega Menu Viewport Meta Visual Composer

+8 more

Microsoft Sharepoint Animate.css Cloudflare Rocket Loader Google Maps (Non Paid Users) ETQ Reliance QMS Normalize.css Wordpress Microsoft Exchange Online

- **Sector:** Research
- **Industry code:** NAICS 325414, 541714, SIC 2834, 2836
- **Region:** Bayern
- **Revenue:** 2M a year, as listed
- **Full record:** [Every detail in the company directory](https://millionrounds.com/directory/catalym)

## Research in Germany

Startups like it

- [**SphingoTec** Hennigsdorf · founded 2002 *Raised*](https://millionrounds.com/company/sphingotec)
- [**mbiomics GmbH** Neuried · founded 2020 *Raised*](https://millionrounds.com/company/mbiomics-gmbh)
- [**PreOmics** Planegg · founded 2016 *Raised*](https://millionrounds.com/company/preomics)
- [**Cellex Cell Professionals** Cologne · founded 2001](https://millionrounds.com/startup/cellex-cell-professionals)
- [**Isarna Therapeutics GmbH** Graefelfing · founded 1998](https://millionrounds.com/startup/isarna-therapeutics-gmbh)
- [**NVision Quantum Technologies** Ulm · founded 2015](https://millionrounds.com/startup/nvision-quantum-technologies)
- [**Resolve Biosciences** Monheim am Rhein · founded 2020](https://millionrounds.com/startup/resolve-biosciences)
- [**SciRhom** Planegg · founded 2016](https://millionrounds.com/startup/scirhom)

## Is this your company?

Add your raise, your deck and your story, and put CatalYm GmbH in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)